#CreativeDisruption on AI, Advanced Therapies and Biologics Strategies

What are the latest trends, developments and strategies in AI for emerging biotech, Advanced Therapies and Biologics. This is what we are going to discuss in our Friday 12 December Creative Disruption Forum at the ARC West London in Hammersmith. Here are some initial thoughts on what could be discussed.

Artificial Intelligence (AI) is transforming the landscape of biotechnology, particularly in the sectors of Biologics and Advanced Therapies in the UK. The integration of AI technologies into research and development processes is enabling quicker drug discovery, enhanced predictive modeling, and improved clinical trial designs.

One notable trend is the use of machine learning algorithms to analyze vast datasets, allowing for the identification of new biomarkers and therapeutic targets. Researchers can leverage AI to predict how biological systems will respond to certain treatments, thus optimizing the design of biologics and advanced therapies tailored to individual patient needs.

Strategically, UK biotech firms are increasingly forming partnerships with tech companies to harness AI capabilities. These collaborations facilitate access to advanced data analytics, enhancing the efficiency of research pipelines. The government also supports this trend through funding initiatives aimed at fostering AI innovations in biotech.

Moreover, AI applications in drug repurposing are gaining traction, allowing companies to effectively reposition existing drugs for new indications, thus accelerating the development timeline and reducing costs. As the UK continues to embrace AI, it is well-positioned to maintain its leadership in the Biologics and Advanced Therapies sectors, driving forward both scientific advancements and commercial success.

Keynotes interviews to be announced soon.

10-10.30 am arrival with coffee & teas, biscuits & fruit

10.30-11.45 am - keynote interviewees

11.45-12 pm - coffee & tea break

12-1.00 pm - Keynote interviews including a panel

1-2 pm - light lunch with coffee + refreshments

2-3 pm - 6-8 workshops with a Group Leader on each - a great way for everyone to get to know each other.

3-3.45 - coffee & tea break -The workshop Group Leaders overview their discussions

3.45.-4.00 - Tony Sedgwick summaries the day with the group

4.00 pm - End

4.00 pm Onwards - Unofficial Christmas Drinks and Networking

More General Information about the Creative Disruption Forum

At all our events, we encourage dialogue in the room with the keynotes and participants expertly moderated by our resident thought leader, Prof Tony Sedgwick. Tony and I have worked together developing our Agile Leaders, Biotech Buddies, #coffeebuddies and now our Creative Disruption Forums over the last eight years. During the pandemic, we did 3-4 #coffeebuddies "shows" weekly, linking our UK community to others worldwide. Our aim for each participant in all our events is to be engaging, informative and entertaining - with no more death by PowerPoint! lol

To spark new thoughts and ideas and build friendships

As organisers, we promise always to entertain, engage, inform and be interactive during our thought-leadership interviews and Creative Disruption workshops. This is to help you spark new thoughts and ideas and build friendships with peers, clients and collaborators.

How do you benefit from attending?

As a "Leader" in the biotech sector, or aspiring leader, you will benefit from this "Creative Disruption" Forum. It will allow you to share common challenges and build deeper connections and trust with your peers. In turn, the aim is to build your confidence when working in areas typically outside your comfort zone by learning and discussing with this / your "Agile" peer-to-peer network.

You can broaden your understanding of the key aspects of the commercialisation journey and how to overcome potential barriers. You can speak to people in a similar position about issues you may not have the opportunity to talk about elsewhere. You can discuss your challenges by learning from other people's experiences to help you find a solution or spark an idea. Why let leaders of emerging companies reinvent the wheel to be successful when we can learn from the experiences of others who have faced similar challenges before?

Chatham House Rules apply - "what goes on in the Forum, stays in the Forum - so to speak!"

Our mission is to help you build your innovation-enabled healthcare business so it is "fit for purpose," genuinely innovative and attractive to the global markets. Helping you build solid, trustworthy networks with your peer group and help spread your creative R&D business network nationally and internationally. Our motivation and focus are on helping you build long-term reliable business relationships and support you on your journey through our supportive business community.

Prof Tony Sedgwick, the self-professed www.ThoughtDisruptor.com, facilitates this workshop. Tony has an esteemed career in academia and business; he is a trained pathologist. His accolades include once being the Global Head of Clinical Reseach at Roche AG, being a VC and being one of the UK's first Biotech CEOs. Tony has now been CEO of four life science companies, Chairman of over 10 Companies, and held many positions within the academic community. He is also an active psychologist, which has helped him develop his passion for "Agile" community group development. He is a Jiu-Jitsu Grand Master VIII and Jiu-Jitsu trainer. Last year, Tony published the book "The Mighty Advisor", which became a number 1 best seller in the Amazon STEM Business Management category.

We will start this Creative Disruption Forum on Friday 12 December with a 10.00 am arrival (followed by a prompt 10.30 am start with interviews of prominent thought leaders). We will end the official program at 3.30 pm, and then go on somewhere for some "unofficial networking" drinks for those that want it. It is our Christmas special after all.

We promise that our #CreativeDisruption Forum will be like no other life sciences event or business network you have experienced. You will be walking out of the session inspired, educated and more connected.

ADMISSION FEE for Service Companies such as CROs, CDMOs, Law Firms and Patent Attorneys, Consultancy Firms = £90 - ALL-INCLUSIVE

ADMISSION FEE for Innovative Emerging Life Science Companies and Independent Consultants = £45

Investors can apply for free entry by writing to graham@biosell.co.uk.